Products & ReviewLife Sciences

Tranylcypromine

Epigenetic modifier; Inhibits lysine-specific demethylase 1 (LSD1)

STEMCELL Technologies Inc.

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our  Product Directory.

Ease of Use
After Sales Service
Value for Money
Write your own review

Tranylcypromine is an epigenetic modifier that is an irreversible inhibitor of Lysine-Specific Demethylase 1 (LSD1, IC₅₀ = 20.7 µM). The catalytic site of LSD1 shares similarity with monoamine oxidase (MAO) enzymes and Tranylcypromine also inhibits MAO A (IC₅₀ = 2.3 µM) and MAO B (IC₅₀ = 0.95 µM). (Lee et al., Schmidt and McCafferty)

REPROGRAMMING

  • Enables chemical reprogramming (without genetic factors) of mouse embryonic fibroblasts to induced pluripotent stem (iPS) cells, in combination with CHIR99021, Forskolin, Valproic Acid, 3-Deazaneplanocin A, and E-616452 (Hou et al.).
  • Promotes reprogramming of human keratinocytes to iPS cells using only 2 factors (OCT4 and KLF4), in combination with CHIR99021 (Li et al.).
  • Converts mouse epiblast-like stem cells to a more primitive embryonic stem (ES)-like state, in combination with several other small molecules (Zhou et al.).

MAINTENANCE AND SELF-RENEWAL

  • Inhibits proliferation of mouse neural stem cells (Sun et al.).
  • Blocks differentiation of mouse ES cells as well as the differentiation-induced demethylation of ES-specific enhancers (Whyte et al.).

Product Overview

Links